Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention.
暂无分享,去创建一个
John A Spertus | David J Cohen | John S Rumsfeld | J. Messenger | J. Spertus | J. Rumsfeld | D. Cohen | K. Kennedy | J. House | S. Marso | Kevin F Kennedy | Amit P Amin | John C Messenger | Sunil V Rao | A. Amin | Steven P Marso | John A House | S. Rao | D. Cohen | D. Cohen
[1] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[2] Peter C. Austin,et al. The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[3] H. White,et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. , 2007, Journal of the American College of Cardiology.
[4] David P Miller,et al. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. , 1996, The New England journal of medicine.
[5] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[6] G. Imbens. The Role of the Propensity Score in Estimating Dose-Response Functions , 1999 .
[7] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.
[8] B. Gersh,et al. Bivalirudin during primary PCI in acute myocardial infarction. , 2008, The New England journal of medicine.
[9] M. Müllner,et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. , 2004, JAMA.
[10] Joseph P Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[11] Eric Peterson,et al. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. , 2006, Journal of the American College of Cardiology.
[12] H V Anderson,et al. The American College of Cardiology-National Cardiovascular Data Registry™ (ACC-NCDR™): building a national clinical data repository , 2001 .
[13] P. Austin. Goodness‐of‐fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score , 2008, Pharmacoepidemiology and drug safety.
[14] S. Yusuf,et al. Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes , 2006, Circulation.
[15] T. Thom,et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee : Heart disease and stroke statistical-2006 update : A report from the American Heart Association Statistics Committee and Stroke statistics subcommittee , 2006 .
[16] A. Laupacis,et al. Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies. , 2004, The American journal of medicine.
[17] R. Bender,et al. Calculating confidence intervals for the number needed to treat. , 2001, Controlled clinical trials.
[18] P. Rosenbaum,et al. Invited commentary: propensity scores. , 1999, American journal of epidemiology.
[19] Deepak L. Bhatt,et al. Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative , 2004 .
[20] D. Rubin,et al. Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score , 1985 .
[21] G. Stone,et al. Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. , 2008, Journal of the American College of Cardiology.
[22] A. Yan,et al. Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry. , 2009, Archives of internal medicine.
[23] A. Laupacis,et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. , 2005, JAMA.
[24] W. Weaver,et al. The Influence of Clinical Risk Factors on the Use of Angiography and Revascularization After Acute Myocardial Infarction , 1995 .
[25] K. Hammermeister,et al. The American College of Cardiology National Database: Progress and challenges , 1997 .
[26] Sunil V. Rao,et al. Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry , 2009, Circulation. Cardiovascular interventions.
[27] N. Weissman,et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. , 2003, The American journal of cardiology.
[28] B. Strauss,et al. Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries. , 2005, American heart journal.
[29] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[30] R. Moore,et al. Using Numerical Results from Systematic Reviews in Clinical Practice , 1997, Annals of Internal Medicine.
[31] E. Topol,et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. , 2007, The American journal of cardiology.
[32] B. Armstrong,et al. Ordinal regression models for epidemiologic data. , 1989, American journal of epidemiology.
[33] R. Brindis,et al. Risk of local adverse events following cardiac catheterization by hemostasis device use - phase II. , 2005, The Journal of invasive cardiology.
[34] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[35] F. McAlister,et al. Exploring the treatment-risk paradox in coronary disease. , 2007, Archives of internal medicine.
[36] J. Spertus,et al. Chronic total occlusion angioplasty in the United States. , 2009, JACC. Cardiovascular interventions.
[37] E. Topol,et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). , 2004, The American journal of cardiology.
[38] B. Gersh,et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial , 2009, The Lancet.
[39] K. Eagle,et al. Predictors of length of stay after coronary stenting. , 2001, American heart journal.
[40] Deepak L. Bhatt,et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. , 2005, JAMA.
[41] E. Topol,et al. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. , 2004, Journal of the American College of Cardiology.
[42] A. Kastrati,et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.
[43] P. Austin. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.
[44] M. Matheny,et al. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. , 2007, American heart journal.
[45] G. Stone,et al. Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial , 2010, Circulation. Cardiovascular interventions.
[46] Patrice Degoulet,et al. The number needed to treat: a clinically useful nomogram in its proper context , 1996, BMJ.
[47] B. Lewis,et al. General cardiology: abstractImportance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients , 2004 .
[48] K. Furie,et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.